Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $67.7B |
| FY2017, ended Dec 31, 2017 | $63.7B |
| FY2018, ended Dec 31, 2018 | $57.8B |
| FY2019, ended Dec 31, 2019 | $78.9B |
| FY2020, ended Dec 31, 2020 | $82.6B |
| FY2021, ended Dec 31, 2021 | $92.1B |
| FY2022, ended Dec 31, 2022 | $90.9B |
| FY2023, ended Dec 31, 2023 | $97.5B |
| FY2024, ended Dec 31, 2024 | $77.3B |
| FY2025, ended Dec 31, 2025 | $69.0B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $74.0B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $25.9B |
| FY2017, ended Dec 31, 2017 | $25.9B |
| FY2018, ended Dec 31, 2018 | $25.9B |
| FY2019, ended Dec 31, 2019 | $25.9B |
| FY2020, ended Dec 31, 2020 | $26.6B |
| FY2021, ended Dec 31, 2021 | $28.7B |
| FY2022, ended Dec 31, 2022 | $31.5B |
| FY2023, ended Dec 31, 2023 | $36.0B |
| FY2024, ended Dec 31, 2024 | $36.4B |
| FY2025, ended Dec 31, 2025 | $38.5B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $39.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.64B | $1.61B |
| FY2017, ended Dec 31, 2017 | $2.83B | $1.58B |
| FY2018, ended Dec 31, 2018 | $3.32B | $2.85B |
| FY2019, ended Dec 31, 2019 | $3.93B | $3.04B |
| FY2020, ended Dec 31, 2020 | $3.56B | $3.10B |
| FY2021, ended Dec 31, 2021 | $4.30B | $3.18B |
| FY2022, ended Dec 31, 2022 | $2.72B | $3.00B |
| FY2023, ended Dec 31, 2023 | $4.96B | $3.60B |
| FY2024, ended Dec 31, 2024 | $4.61B | $3.52B |
| FY2025, ended Dec 31, 2025 | $2.45B | $3.23B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $2.61B | $2.58B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.74B |
| FY2017, ended Dec 31, 2017 | $761M |
| FY2018, ended Dec 31, 2018 | $1.10B |
| FY2019, ended Dec 31, 2019 | $1.33B |
| FY2020, ended Dec 31, 2020 | $3.65B |
| FY2021, ended Dec 31, 2021 | $3.55B |
| FY2022, ended Dec 31, 2022 | $1.95B |
| FY2023, ended Dec 31, 2023 | $1.88B |
| FY2024, ended Dec 31, 2024 | $1.40B |
| FY2025, ended Dec 31, 2025 | $2.19B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $1.63B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $17.3B |
| FY2017, ended Dec 31, 2017 | $17.7B |
| FY2018, ended Dec 31, 2018 | $18.4B |
| FY2019, ended Dec 31, 2019 | $18.5B |
| FY2020, ended Dec 31, 2020 | $20.0B |
| FY2021, ended Dec 31, 2021 | $19.5B |
| FY2022, ended Dec 31, 2022 | $22.9B |
| FY2023, ended Dec 31, 2023 | $19.4B |
| FY2024, ended Dec 31, 2024 | $17.7B |
| FY2025, ended Dec 31, 2025 | $21.2B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $21.0B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 15.9% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.53B |
| FY2017, ended Dec 31, 2017 | 1.49B |
| FY2018, ended Dec 31, 2018 | 1.44B |
| FY2019, ended Dec 31, 2019 | 1.43B |
| FY2020, ended Dec 31, 2020 | 1.41B |
| FY2021, ended Dec 31, 2021 | 1.39B |
| FY2022, ended Dec 31, 2022 | 1.36B |
| FY2023, ended Dec 31, 2023 | 1.35B |
| FY2024, ended Dec 31, 2024 | 1.29B |
| FY2025, ended Dec 31, 2025 | 1.28B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | 1.28B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.60B | $140M |
| FY2017, ended Dec 31, 2017 | $2.17B | $137M |
| FY2018, ended Dec 31, 2018 | $2.02B | $128M |
| FY2019, ended Dec 31, 2019 | $1.48B | $135M |
| FY2020, ended Dec 31, 2020 | $1.39B | $126M |
| FY2021, ended Dec 31, 2021 | $2.11B | $121M |
| FY2022, ended Dec 31, 2022 | $2.02B | $120M |
| FY2023, ended Dec 31, 2023 | $1.55B | $146M |
| FY2024, ended Dec 31, 2024 | $2.33B | $147M |
| FY2025, ended Dec 31, 2025 | $2.38B | $114M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $863M | $125M |
Valuation
At current price- Market Cap
- $80.0B
- P/E
- 30.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.0×
- Price / Book
- 3.1×
- EV / EBITDA
- 19.7×
Growth
Trailing 12 months- Revenue (TTM)
- $39.3B
- Revenue Growth YoY
- 7.8%
- Revenue CAGR 3Y
- 7.0%
- Revenue CAGR 5Y
- 7.7%
- EPS Growth YoY
- −24.9%
- Net Income Growth YoY
- −27.5%
Profitability
Trailing 12 months- Gross Margin
- 28.8%
- Operating Margin
- 9.4%
- Net Margin
- 6.6%
- FCF Margin
- 6.6%
- Return on Equity
- 10.1%
Earnings
Trailing 12 months- Net Income
- $2.61B
- EPS (diluted)
- $2.02
- EBITDA
- $5.05B
- Operating Income
- $3.68B
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $1.63B
- Total Debt
- $21.0B
- Net Debt
- $19.4B
- Total Assets
- $71.1B
- Total Liabilities
- $45.3B
- Shareholders' Equity
- $25.8B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.89B
- Capital Expenditure
- $1.31B
- Free Cash Flow
- $2.58B
Dividends and risk
Last 12 months- Dividend Yield
- 3.2%
- Dividend / Share
- $2.02
- Beta (5Y)
- 0.38
Every ratio is calculated from the company’s reported figures.